Login / Signup

Financial Toxicity from Newly Approved Second-/Third-Line Agents in Metastatic Urothelial Carcinoma.

David J BenjaminMark P LythgoeArash Rezazadeh
Published in: BJU international (2023)
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • drug administration
  • oxidative stress
  • affordable care act
  • childhood cancer
  • oxide nanoparticles
  • health insurance